ENSC: Ensysce Biosciences, Inc. Stock

by  •  • Comments Off on ENSC: Ensysce Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.09
Enterprise Value ($M) 1.95
Book Value ($M) 3.38
Book Value / Share 2.59
Price / Book 1.51
NCAV ($M) 3.13
NCAV / Share 2.40
Price / NCAV 1.63

Profitability (mra)
Return on Invested Capital (ROIC) -1.96
Return on Assets (ROA) -2.95
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.42
Current Ratio 2.42

Balance Sheet (mrq) ($M)
Current Assets 5.34
Assets 5.60
Liabilities 2.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.21
Operating Income -6.73
Net Income -7.99
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.50
Cash from Investing 0.00
Cash from Financing 9.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Perceptive Advisors Llc 0.40 -93.33
11-14 13G Anson Funds Management LP 7.10
11-06 13G Ra Capital Management, L.p. 9.90
2024-02-14 13G/A Lincoln Park Capital Fund, LLC 3.79 -91.74

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 5,435 11,682 46.52
2025-03-13 17,451 65,031 26.83
2025-03-12 5,185 16,656 31.13
2025-03-11 4,459 12,495 35.69
2025-03-10 4,211 12,684 33.20

(click for more detail)

Similar Companies
ELTX – Elicio Therapeutics, Inc. ELUT – Elutia Inc.
ENLV – Enlivex Therapeutics Ltd. ENTO – Entero Therapeutics, Inc.
ENTX – Entera Bio Ltd.


Financial data and stock pages provided by
Fintel.io